[C-11]NOP-1A, [C-11]NPA , nociceptive opioid peptide receptors, dopamine release
Showing 1 - 25 of >10,000
Alcohol Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Alcohol Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh PET Facility
Jul 8, 2022
Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)
Recruiting
- Cocaine Use Disorder
- Baseline [C-11]NPA PET Scan
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh
Jun 27, 2022
Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)
Not yet recruiting
- Opioid Use Disorder
- CVL-354
- +2 more
-
New Haven, ConnecticutNew Haven, Connecticut
Jan 18, 2023
Alcohol Use Disorder Trial in Toronto ([11C]-(+)-PHNO PET scan, Alcohol Self-Administration, Craving Task)
Completed
- Alcohol Use Disorder
- [11C]-(+)-PHNO PET scan
- +4 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Oct 27, 2020
Healthy Volunteers Trial in London (Amphetamine, TAK -041, [11C] (+)-4-propyl-(+)-4-propyl-9-hydroxynaphthoxazine (PHNO))
Completed
- Healthy Volunteers
- Amphetamine
- +2 more
-
London, United KingdomHammersmith Medicines Research
Mar 17, 2021
Cocaine Use Disorder Trial in Pittsburgh ([C-11], NOP-1A)
Completed
- Cocaine Use Disorder
- [C-11]
- NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Aug 2, 2019
Pain, Anxiety, Depression Trial run by the NIMH (NOP-1A)
Completed
- Pain
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Healthy Trial in Pittsburgh (Hydrocortisone, [C-11]NOP-1A)
Completed
- Healthy
- Hydrocortisone
- [C-11]NOP-1A
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 2, 2020
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)
Not yet recruiting
- Alcohol Use Disorder
- Detoxification Program
- +2 more
- (no location specified)
Jul 13, 2023
Pain Trial in Houston (anakinra, Placebo, Nociceptive pain challenge)
Recruiting
- Pain
- anakinra
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jan 19, 2022
Opioid Use, Enhanced Recovery After Surgery, Anesthesia Trial in Nashville (Ketamine, Placebo)
Enrolling by invitation
- Opioid Use
- +4 more
- Ketamine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 31, 2023
Cocaine-Related Disorders Trial in Pittsburgh (d-amphetamine, [C-11]NPA)
Completed
- Cocaine-Related Disorders
- d-amphetamine
- [C-11]NPA
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Sep 2, 2020
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Hip Arthropathy, Hip Disease Trial in Montauban (Dexmedetomidine, Sufentanil)
Recruiting
- Hip Arthropathy
- Hip Disease
-
Montauban, Tarn Et Garonne, FranceEdmundo Pereira de Souza Neto
Jul 6, 2022
Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence Trial (Naltrexone-Bupropion Combination)
Not yet recruiting
- Obesity, Morbid
- +2 more
- Naltrexone-Bupropion Combination
- (no location specified)
Jul 26, 2022
Stress Response Trial (tDCS actif, tDCS Sham)
Not yet recruiting
- Stress Response
- tDCS actif
- tDCS Sham
- (no location specified)
Apr 20, 2023
Pathophysiology of Gilles de la Tourette Syndrome. Part 1:
Not yet recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- PET/MR scanner
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022
Substance Abuse, Suicide, Depression Trial in Houston (Repetitive Transcranial Magnetic Stimulation (rTMS), sham rTMS)
Recruiting
- Substance Abuse
- +2 more
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- sham rTMS
-
Houston, TexasThe Menninger Clinic
Aug 3, 2022
Trigeminal Neuropathy, Traumatic Trial in Paris (BOTOX®, Allergan, Placebo)
Active, not recruiting
- Trigeminal Neuropathy, Traumatic
- BOTOX®, Allergan
- Placebo
-
Paris, FranceGroupe Hospitalier Pitié-Salpêtrière
Jun 27, 2022
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
MDD Trial in Tübingen (Ghrelin, Placebo)
Recruiting
- Major Depressive Disorder
- Ghrelin
- Placebo
-
Tübingen, BW, GermanyDepartment of Psychiatry & Psychotherapy, University of Tübingen
Apr 7, 2022
Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release
Not yet recruiting
- Moderate to Severe Opioid Use Disorder
- Extended Release Subcutaneous Buprenorphine
- Immediate Release Sublingual Buprenorphine
-
Barrie, Ontario, Canada
- +4 more
Oct 20, 2022
Pain, Chronic, Opioid Dependence, Opioid Use Trial in New York (Root.Health Dietary Supplement)
Enrolling by invitation
- Pain, Chronic
- +3 more
- Root.Health Dietary Supplement
-
New York, New YorkHudson Medical
Jun 9, 2023